MapLight Therapeutics Market Sentiment

SPY773.01−0.01%QQQ724.85−0.05%BTC/USD84,667.70+2.09%DIA527.72+0.00%GLD379.65+0.18%TLT80.240.00%

Premium

MapLight Therapeutics Inc

MPLTNASDAQ

Trade with Public

$8.16

-0.08-0.97%

Last update: Oct 21, 5:24 AM

$8.35

0.111.33%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

MapLight Therapeutics Market Sentiment - Benzinga

MapLight Therapeutics Market Sentiment

Market sentiment signals for MapLight Therapeutics (MPLT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 9.8% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

13 analysts

Options Flow (P/C)

0.00

More calls — Bullish

34 calls · 0 puts

Avg Consensus PT

$32

+288.6%

Highest Price Target

$46

+450.9%

Raymond James

Lowest Price Target

$13

+55.7%

UBS

Short Interest

9.8%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 6, 2026	Guggenheim	Delma Caiati—	—	—	Initiate	Neutral
Aug 31, 2026	Needham	Ami Fadia—	+415.0%	$45 → $43	Maintained	Buy
Aug 10, 2026	UBS	Ashwani Verma—	+55.7%	$52 → $13	Downgrade	Buy→Neutral
Jul 28, 2026	Canaccord Genuity	Sumant Kulkarni—	+187.4%	$43 → $24	Maintained	Buy
Jul 28, 2026	Morgan Stanley	Sean Laaman—	+151.5%	$34 → $21	Downgrade	Overweight→Equal-Weight
Jul 28, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+211.4%	$45 → $26	Maintained	Buy
Jul 24, 2026	Canaccord Genuity	Sumant Kulkarni—	+415.0%	$35 → $43	Maintained	Buy
Jul 21, 2026	UBS	Ashwani Verma—	+522.8%	$48 → $52	Maintained	Buy
Jul 21, 2026	BMO Capital	Malcolm Hoffman—	+450.9%	$46	Initiate	Outperform
Jul 10, 2026	Needham	Ami Fadia—	+438.9%	$42 → $45	Maintained	Buy
Jun 25, 2026	Raymond James	Tiago Fauth—	+450.9%	$46	Initiate	Strong Buy
Jun 23, 2026	Craig-Hallum	Adam Vogel—	+379.0%	$43 → $40	Maintained	Buy
Jun 22, 2026	Needham	Ami Fadia—	+403.0%	$37 → $42	Maintained	Buy
Jun 2, 2026	Stifel	Paul Matteis—	+331.1%	$28 → $36	Maintained	Buy
May 28, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+438.9%	$45 → $45	Maintained	Buy
May 27, 2026	UBS	Ashwani Verma—	+474.9%	$48	Initiate	Buy
May 21, 2026	Craig-Hallum	Adam Vogel—	+415.0%	$43	Initiate	Buy
May 4, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+438.9%	$45	Initiate	Buy
Apr 8, 2026	Needham	Ami Fadia—	+343.1%	$37	Initiate	Buy
Apr 7, 2026	TD Cowen	Joseph Thome—	—	—	Initiate	Buy
Mar 19, 2026	Canaccord Genuity	Sumant Kulkarni—	+319.2%	$35	Initiate	Buy
Nov 21, 2025	Stifel	Paul Matteis—	+235.3%	$28	Initiate	Buy
Nov 21, 2025	Jefferies	Andrew Tsai—	+283.2%	$32	Initiate	Buy
Nov 21, 2025	Leerink Partners	Marc Goodman—	+259.3%	$30	Initiate	Outperform
Nov 21, 2025	Morgan Stanley	Sean Laaman—	+307.2%	$34	Initiate	Overweight

More with Benzinga EdgeGet Access

MapLight Therapeutics Inc

MapLight Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch